Brief: Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
18/05/2023 06:00
May 18 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID
PRICE
DEFICIENCY
Source text for Eikon: ID:nGNX8BtKw
Further company coverage: ADXN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand